Survival Bump in Ovarian Cancer With Cediranib (CME/CE)

AMSTERDAM (MedPage Today) -- Survival in recurrent ovarian cancer increased significantly in patients who received a targeted agent with chemotherapy and as maintenance therapy, results of a randomized trial showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/10/survival-bump-in-ovarian-cancer-with.html